Private Advisor Group LLC reduced its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 35.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 18,367 shares of the pharmacy operator’s stock after selling 9,909 shares during the quarter. Private Advisor Group LLC’s holdings in Walgreens Boots Alliance were worth $1,355,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Commonwealth Bank of Australia grew its stake in shares of Walgreens Boots Alliance by 139.5% during the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after purchasing an additional 26,893 shares during the period. Andra AP fonden grew its stake in shares of Walgreens Boots Alliance by 6.9% during the 3rd quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock valued at $4,811,000 after purchasing an additional 4,000 shares during the period. Birinyi Associates Inc. grew its stake in shares of Walgreens Boots Alliance by 9.0% during the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after purchasing an additional 750 shares during the period. Chesley Taft & Associates LLC grew its stake in shares of Walgreens Boots Alliance by 48.6% during the 4th quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock valued at $18,981,000 after purchasing an additional 85,423 shares during the period. Finally, CI Investments Inc. bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $27,555,000. Institutional investors and hedge funds own 61.57% of the company’s stock.
Walgreens Boots Alliance Inc (WBA) opened at $70.92 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00. The company has a market capitalization of $71,410.00, a P/E ratio of 19.59, a P/E/G ratio of 1.17 and a beta of 1.18.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. During the same period in the previous year, the firm earned $1.10 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. analysts anticipate that Walgreens Boots Alliance Inc will post 5.73 earnings per share for the current year.
Walgreens Boots Alliance announced that its board has initiated a share buyback program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.26%. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.
In other Walgreens Boots Alliance news, insider Stefano Pessina purchased 98,858 shares of the stock in a transaction that occurred on Monday, January 15th. The shares were bought at an average cost of $76.07 per share, with a total value of $7,520,128.06. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 14.80% of the stock is currently owned by insiders.
A number of research analysts have recently weighed in on WBA shares. Pivotal Research lowered their price objective on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a research report on Tuesday, October 24th. Mizuho set a $94.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Tuesday, October 24th. Royal Bank of Canada reaffirmed a “buy” rating and set a $88.00 price objective on shares of Walgreens Boots Alliance in a research report on Wednesday, October 25th. Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. Finally, Jefferies Group set a $93.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, October 29th. Ten research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. Walgreens Boots Alliance presently has an average rating of “Buy” and a consensus target price of $85.05.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.thelincolnianonline.com/2018/02/18/private-advisor-group-llc-sells-9909-shares-of-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.